Longboard Pharmaceuticals LBPH announced that it is set to be acquired by Lundbeck A/S for $60 per share in cash, which ...

H. Lundbeck plans to acquire Longboard Pharmaceuticals in a $2.6 billion deal, the companies announced Monday.

Lundbeck’s acquisition of Longboard Pharmaceuticals is meant to bolster its neuro-rare disease franchise, the drugmaker ...

On Tuesday, Longboard Pharmaceuticals Inc (LBPH) stock saw a modest uptick, ending the day at $59.4 which represents a slight increase of $0.06 or 0.10% from the prior close of $59.34. The stock ...

The acquisition will add a late-stage drug candidate with blockbuster potential to Lundbeck’s neuroscience pipeline.

智通财经APP获悉，丹麦制药巨头Lundbeck表示将以26亿美元的股权价值收购Longboard Pharmaceuticals ...

Lundbeck, a global drugmaker based in Denmark, has agreed to buy La Jolla-based Longboard Pharmaceuticals for $2.6 billion to ...

Longboard Pharmaceuticals is being acquired by Lundbeck for $60 per share, valuing the deal at $2.6 billion, driven by the potential of bexicaserin. Bexicaserin shows promising seizure reduction ...

Nose riding is more difficult than it looks but with these tips from the master, you’ll soon be on your way to hanging ten.

Rachael Tilly and Taylor Jensen won the Surf City El Salvador Longboard Championships to claim 2024 World Longboard Titles.

It was a second title for Rachael Tilly, who in 2015 was the youngest-ever to earn the longboard championship, and a fourth ...

Longboard Pharmaceuticals Inc.的股价达到了前所未有的里程碑，飙升至历史最高点59.48美元。这一显著的峰值反映了该生物制药公司一年内惊人的1048.94%的涨幅，表明其增长轨迹强劲。投资者对Longboard的潜力表现出越来越大的信心，随着公司在开发神经系统疾病新疗法方面继续取得重大进展，推动股价达到新高。股价创历史新高凸显了市场对Longboard创新方法和未来前景 ...